Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 16956535)

1.

[Treatment of viral hepatitis (I). Treatment of chronic hepatitis B].

Sánchez-Quijano A, Lissen E.

Enferm Infecc Microbiol Clin. 2006 Aug-Sep;24(7):453-61; quiz 462. Review. Spanish.

PMID:
16956535
2.

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.

3.

Management of chronic hepatitis B.

Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.

4.

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.

Liaw YF.

Liver Int. 2009 Jan;29 Suppl 1:100-7. doi: 10.1111/j.1478-3231.2008.01941.x. Review.

PMID:
19207972
5.

Diagnosis and treatment of chronic hepatitis B: an update.

Morgan M, Park W, Keeffe EB.

Minerva Gastroenterol Dietol. 2007 Mar;53(1):25-41. Review.

PMID:
17415343
6.

Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

Rivkin A.

Drugs Today (Barc). 2007 Apr;43(4):201-20. Review.

PMID:
17460784
7.

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL.

J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41.

PMID:
12472960
8.

Treatment of chronic hepatitis B.

Mohanty SR, Kupfer SS, Khiani V.

Nat Clin Pract Gastroenterol Hepatol. 2006 Aug;3(8):446-58. Review.

PMID:
16883349
9.

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

Yim HJ, Lok AS.

Hepatology. 2006 Feb;43(2 Suppl 1):S173-81. Review.

PMID:
16447285
10.

Diagnosis and treatment of chronic hepatitis B: 2009 update.

Morgan M, Keeffe EB.

Minerva Gastroenterol Dietol. 2009 Mar;55(1):5-22. Review.

PMID:
19212304
11.

Chronic hepatitis B: a wider range of therapeutic options.

[No authors listed]

Prescrire Int. 2007 Aug;16(90):157-62.

PMID:
17724844
12.

Entecavir: a new treatment option for chronic hepatitis B.

Zoulim F.

J Clin Virol. 2006 May;36(1):8-12. Epub 2006 Mar 3. Review.

PMID:
16515882
13.
14.

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.

Shouval D, Lai CL, Chang TT, Cheinquer H, Martin P, Carosi G, Han S, Kaymakoglu S, Tamez R, Yang J, Tenney D, Brett-Smith H.

J Hepatol. 2009 Feb;50(2):289-95. doi: 10.1016/j.jhep.2008.10.017. Epub 2008 Nov 19.

PMID:
19070393
15.
16.

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B.

Vassiliadis T, Tziomalos K, Patsiaoura K, Zagris T, Giouleme O, Soufleris K, Grammatikos N, Theodoropoulos K, Mpoumponaris A, Dona K, Zezos P, Nikolaidis N, Orfanou-Koumerkeridou E, Balaska A, Eugenidis N.

J Gastroenterol Hepatol. 2007 Oct;22(10):1582-8. Epub 2007 Aug 7.

PMID:
17683500
17.

Chronic hepatitis B: who to treat and which choice of treatment?

Di Marco V, Craxì A.

Expert Rev Anti Infect Ther. 2009 Apr;7(3):281-91. doi: 10.1586/eri.09.4. Review.

PMID:
19344242
18.

Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B.

Sarin SK, Sood A, Kumar M, Arora A, Amrapurkar D, Sharma BC, Konar A, Chawla YK, Jain RK, Nanda V, Kumar A, Hissar S, Lavate P, Lahoti D; National Collaborative Group on Hepatitis B, India.

Am J Gastroenterol. 2007 Jan;102(1):96-104.

PMID:
17266689
19.

Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.

Akman SA, Okcu SC, Halicioğlu O, Sutcuoglu S, Anil M, Kizilgunesler A, Bakiler AR.

Pediatr Int. 2007 Dec;49(6):848-52.

PMID:
18045284
20.

Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B.

Mihm U, Chan HL, Zeuzem S, Chim AM, Hui AY, Wong VW, Sung JJ, Herrmann E.

Antivir Ther. 2008;13(8):1029-37.

PMID:
19195328
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk